Nykode Therapeutics Presents at DNB Carnegie Nordic Healthcare Conference

PUBT · 1d ago
Nykode Therapeutics Presents at DNB Carnegie Nordic Healthcare Conference
  • Nykode Therapeutics will attend the 17th DNB Carnegie Nordic Healthcare Conference in Oslo on November 24, 2026.
  • CEO Michael Engsig and Chief Scientific Officer Agnete Fredriksen will lead a presentation and fireside chat from 2:45–3:05 p.m. CET.
  • Discussion will cover pipeline developments, including abi-suva’s Phase 2 Abili-T trial, individualized cancer vaccine VB10.NEO and the immune tolerance platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nykode Therapeutics AS published the original content used to generate this news brief via NewsWeb, the disclosure sustem operated by Euronext Oslo (Ref. ID: 202611200600OSLOBORSNEWS__EN_378160310CFD099F888BEA389BDBCAF), on November 20, 2026, and is solely responsible for the information contained therein.